SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Landec Corporation on December 2, 2004. The filing reports corporate governance changes effective as of the report date. Note: The request metadata referenced "LIFECORE BIOMEDICAL, INC.", but the source text explicitly identifies the registrant as Landec Corporation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and does not contain financial performance data.
Material Changes
- Board Election: The Board of Directors elected Robert Tobin as a new member of the Board of Directors and the Compensation Committee, effective December 2, 2004. Mr. Tobin serves as a Class II Director.
- Bylaw Amendment: The Board approved an amendment and restatement of the Company's Bylaws to increase the number of directors from eight (8) to nine (9).
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the background and qualifications of the newly elected director, Robert Tobin.
- Review the attached Exhibit 3.1 (Amended and Restated Bylaws) for specific details on the governance structure changes.
- Confirm the total number of directors on the board is now nine.